Alpha agonist dexmedetomidine may reduce duration of delirium in critically ill adults.

Evid Based Nurs

Health Technology Assessment Group, University of Central Lancashire, Preston, Lancashire, UK.

Published: June 2020

Download full-text PDF

Source
http://dx.doi.org/10.1136/ebnurs-2019-103215DOI Listing

Publication Analysis

Top Keywords

alpha agonist
4
agonist dexmedetomidine
4
dexmedetomidine reduce
4
reduce duration
4
duration delirium
4
delirium critically
4
critically ill
4
ill adults
4
alpha
1
dexmedetomidine
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!